supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Tyrosine
drug:
Oprelvekin
Research Papers that Mention the Interaction
“In the DU-145 prostate carcinoma cell line, rhIL-11 stimulates a transient and dose-dependent increase in the tyrosine 705-phosphorylated, active form of STAT3 (STAT3 P-Tyr705), involved in the downstream signaling of IL-11R and other members of the gp130-dependent receptors.”
Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback